Sign In
Buy ABC
$179.98
+0 (+0%)
At Close: Nov 28, 2023
These 7 Cannabis Stocks May Be Underappreciated As Market Continues To Rebound
05:01pm, Monday, 28'th Mar 2022 Benzinga
Over the past couple of months, the cannabis sector has faced many challenges resulting in marijuana stocks dropping.
Some of the factors include a slowdown in January sales, rising interest rates, co
AmerisourceBergen Announces Date and Time for Second Quarter Fiscal 2022 Earnings Release; Announces 2022 Investor Day
04:40pm, Monday, 28'th Mar 2022
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AmerisourceBergen Corporation (NYSE: ABC) today announced that it plans to release its results for the Second Quarter of Fiscal 2022 on Wednesday, May 4, 2022, prio
3 Healthcare Stocks With Healthy Fundamentals
04:00am, Friday, 25'th Mar 2022
These three fundamentally sound companies will protect both your vitals and your financial livelihood for years to come.
Why Holding Centene (CNC) in Your Portfolio is a Smart Move
05:53pm, Monday, 21'st Mar 2022 Zacks Investment Research
Banking on a robust portfolio, buyouts and alliances plus contract wins, Centene (CNC) holds prospects to reap benefits for investors.
UnitedHealth Group (UNH) Gains 38% in a Year: More Room to Run?
05:04pm, Monday, 21'st Mar 2022 Zacks Investment Research
Continued revenue growth, management optimism surrounding the Medicaid business, several contract wins, and solid cash balance continue to drive UnitedHealth Group (UNH).
Align Technology (ALGN) Debuts Latest Feature for ClinCheck
02:28pm, Monday, 21'st Mar 2022 Zacks Investment Research
Align Technology's (ALGN) CBCT integration feature for ClinCheck will enable doctors to treat a broader range of cases with the Invisalign clear aligners.
The Zacks Analyst Blog Highlights Exxon Mobil, Wells Fargo, CME Group, JPMorgan Chase, and AmerisourceBergen
01:21pm, Friday, 18'th Mar 2022 Zacks Investment Research
Exxon Mobil, Wells Fargo, CME Group, JPMorgan Chase, and AmerisourceBergen are part of today's Analyst blog.
Top Research Reports for Exxon Mobil, Wells Fargo & CME Group
03:39pm, Thursday, 17'th Mar 2022 Zacks Investment Research
Today's Research Daily features new research reports on 12 major stocks, including Exxon Mobil Corporation (XOM), Wells Fargo & Company (WFC) and CME Group Inc. (CME).
Here's Why You Should Retain ResMed (RMD) Stock for Now
02:34pm, Thursday, 17'th Mar 2022 Zacks Investment Research
ResMed's (RMD) robust international performance and an ongoing rebound in device sales instill investor confidence in the stock.
Why Holding Anthem (ANTM) in Your Portfolio is a Prudent Move
05:24pm, Wednesday, 16'th Mar 2022 Zacks Investment Research
Riding high on better membership, a robust portfolio and operational excellence, Anthem (ANTM) holds potential to reap benefits for investors.
Here's Why You Should Hold on to Integra (IART) Stock for Now
02:13pm, Wednesday, 16'th Mar 2022 Zacks Investment Research
Investors are optimistic about Integra's (IART) better-than-expected results and robust segmental performance.
Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?
01:40pm, Wednesday, 16'th Mar 2022 Zacks Investment Research
Here is how AmerisourceBergen (ABC) and Catalyst Pharmaceutical (CPRX) have performed compared to their sector so far this year.
Is AmerisourceBergen (ABC) Outperforming Other Medical Stocks This Year?
11:17am, Wednesday, 16'th Mar 2022
Here is how AmerisourceBergen (ABC) and Catalyst Pharmaceutical (CPRX) have performed compared to their sector so far this year.
HCA Healthcare (HCA) Up 43.1% in a Year: Is More Upside Left?
05:38pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
Growing revenues, numerous acquisitions and a sturdy financial standing continue to drive HCA Healthcare (HCA).
Exact Sciences (EXAS) Cologuard Sales Up but Costs Rise
03:34pm, Tuesday, 15'th Mar 2022 Zacks Investment Research
Following the acquisitions of Paradigm and Ashion, Exact Sciences (EXAS) is offering therapy selection tests for patients with advanced cancer.
